Comparison of disaccharides in hypothermic pulmonary preservation: Is efficacy simply related to the molecular weight?

被引：0

作者：

Fukuse, T ^{[1
]}

Hirata, T ^{[1
]}

Nakamura, T ^{[1
]}

Kawashima, M ^{[1
]}

Liu, CJ ^{[1
]}

Ueda, M ^{[1
]}

Hitomi, S ^{[1
]}

Wada, H ^{[1
]}

机构：

[1] Kyoto Univ, Chest Dis Res Inst, Dept Thorac Surg, Sakyo Ku, Kyoto 606, Japan

来源：

TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 07期

关键词：

D O I：

10.1016/S0041-1345(98)01069-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：3380 / 3381

页数：2

共 50 条

[41] Efficacy of an intravenous low-molecular-weight dermatan sulphate (Desmin) in patients with acute proximal deep venous thrombosis and silent pulmonary embolism. A pilot study
Venosi, S
Zamboni, V
Irace, L
Stumpo, R
Massa, R
Palazzini, E
Valentini, FB
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1997, 25 (02) : 98 - 107
[42] COMPARISON OF LOW-MOLECULAR WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN IN PROPHYLAXIS OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM IN TOTAL HIP-REPLACEMENT
ERIKSSON, BI
ERIKSSON, E
WADENVIK, H
TENGBORN, L
RISBERG, B
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 470 - 470
[43] Fondaparinux (Arixtra) in comparison to (low molecular weight) heparin for the initial treatment of symptomatic deep venous thrombosis or pulmonary embolism - The Matisse clinical outcome studies.
BLOOD, 2002, 100 (11) : 83A - 83A
[44] PREVENTION OF PULMONARY-EMBOLISM IN SPINAL-CORD INJURED PATIENTS - COMPARISON OF NO FIXED-DOSE HEPARIN VERSUS LOW-MOLECULAR-WEIGHT HEPARIN
MACOUILLARD, G
CASTAGNERA, L
CLAVERIE, JP
SIMEON, F
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 978 - 978
[45] IMMUNOHISTOCHEMICAL COMPARISON OF CUTANEOUS HISTIOCYTOSES AND RELATED SKIN DISORDERS - DIAGNOSTIC AND HISTOGENETIC RELEVANCE OF MS-1 HIGH-MOLECULAR-WEIGHT PROTEIN EXPRESSION
GOERDT, S
KOLDE, G
BONSMANN, G
HAMANN, K
CZARNETZKI, B
ANDREESEN, R
LUGER, T
SORG, C
JOURNAL OF PATHOLOGY, 1993, 170 (04): : 421 - 427
[46] Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin - A comparison of patient self-injection with homecare injection
Wells, PS
Kovacs, MJ
Bormanis, J
Forgie, MA
Goudie, D
Morrow, B
Kovacs, J
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (16) : 1809 - 1812
[47] PREVENTION OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM AFTER TOTAL HIP-REPLACEMENT - COMPARISON OF LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN
ERIKSSON, BI
KALEBO, P
ANTHMYR, BA
WADENVIK, H
TENGBORN, L
RISBERG, B
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1991, 73A (04): : 484 - 493
[48] Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials
Elbadawi, Ayman
Shnoda, Mina
Mahmoud, Karim
Elgendy, Islam Y.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 380 - 388
[49] Comparison of unfractionated versus low molecular weight heparin for deep vein thrombosis prophylaxis during breast and pelvic cancer surgery: Efficacy, safety, and follow-up
Heilmann, L
Tempelhoff, GFV
Kirkpatrick, C
Schneider, DM
Hommel, G
Pollow, K
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1998, 4 (04) : 268 - 273
[50] Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation
Fanikos, J
Tsilimingras, K
Kucher, N
Rosen, AB
Hieblinger, MD
Goldhaber, SZ
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02): : 247 - 250

← 1 2 3 4 5 →